Developer docs
API playgroundTry for free, no card

Search company profiles

Prestige Brands Holdings

Full company profile

uuid002sqbq

Namestring
Prestige Brands Holdings
Legal namestring
Prestige Consumer Healthcare Inc.
Company typeenum
Public
Founded yearint
1920
Descriptiontext

Prestige Consumer Healthcare Inc. (NYSE: PBH), historically Prestige Brands Holdings, is a publicly traded US-based consumer healthcare company that markets, sells, manufactures, and distributes over-the-counter (OTC) healthcare products. Founded around 1920 and headquartered in Tarrytown, NY, with manufacturing in Lynchburg, VA, the company describes itself as the largest independent provider of OTC products in North America and operates across the US, Canada, and Australia via its Care Pharmaceuticals subsidiary.

The company's product portfolio spans eight OTC categories (Digestive Care, Eye/Ear/Nose/Throat, Oral Care, Pediatric Care, Pain Relief, Skin Care, Sleep Aids, and Women's Health) and includes multiple #1 category leaders such as Chloraseptic, Clear Eyes, Compound W, Monistat, Fleet, Boudreaux's Butt Paste, Nix, and TheraTears. Business model is a brand-acquisition roll-up: Prestige acquires and operates heritage OTC brands (with histories ranging from 40 to 140+ years), then distributes them through pharmacies, mass retailers, and grocery stores at unit retail pricing. Recent inorganic moves include the $1.045 billion Breathe Right acquisition (March 2026) entering the sleep and nasal-strip category, the $150 million LaCorium Australian skin-care deal (2026), and the ~$108.9 million Pillar5 Pharma deal (August 2025), which collectively push pro forma sales to $1.3 billion but push leverage above 4x EBITDA and add non-disclosure-related securities-fraud scrutiny.

Revenue is generated through traditional retail channels with no public pricing or subscription model disclosed; a secondary healthcare-professional recommendation layer and a digital marketing stack (Google Analytics, Facebook/Meta, YouTube, Ketch for privacy) support demand. The product/technology stack is non-software, with no proprietary AI/ML capability or developer-facing platform; competitive advantage rests on brand equity, retail distribution, and category leadership rather than technology differentiation.

Short descriptiontext

Prestige Consumer Healthcare (NYSE: PBH) is the largest independent North American OTC consumer healthcare company, marketing, selling, and distributing an eight-category portfolio of heritage OTC brands through retail and pharmacy channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersLynchburg, United States
HQ citystring
Lynchburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
consumer healthcare products, over-the-counter medications, OTC pharmaceuticals, personal care brands, health and wellness products
Industry4 codes
1Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
CodeCRADAMADPrimaryYes
2OTC & Consumer Health Distributors
CodeHLAIAJACPrimaryNo
3OTC Medicines & Consumer Health Products Distribution
CodeCRAOAHABPrimaryNo
4Nonfood Grocery & HBC Wholesale (Paper, Cleaning, Personal Care)
CodeAFAIABALPrimaryNo
NAICS code2 codes
  • Pharmacies and Drug Retailers456110
  • Other Health and Personal Care Retailers45619
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Over-the-Counter (OTC) Consumer Healthcare Products
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Consumer Healthcare Product Sales
TypeOne Time License
Description

Prestige Consumer Healthcare generates revenue through the sale of over-the-counter (OTC) healthcare products. The company manufactures and distributes a portfolio of trusted consumer healthcare brands including digestive care, eye/ear/nose/throat, oral care, pediatric care, pain relief, skin care, sleep aids, and women's health products. Revenue is generated through retail distribution channels including pharmacies, mass retailers, and grocery stores.

prestigebrands.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure
Pricing details1 tier
1Consumer OTC healthcare products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products are sold at retail price points through pharmacies, mass retailers, and grocery stores. Specific pricing varies by product and retailer.

prestigebrands.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 18 records shown
1Dramamine
Description

Motion sickness relief and prevention products

prestigebrands.com
+17 more records
Core offering1 text field

Prestige Consumer Healthcare (NYSE: PBH) is the largest independent provider of over-the-counter (OTC) consumer healthcare products in North America. The company markets, manufactures, and distributes a portfolio of trusted legacy brands — including Dramamine, Tagamet, Chloraseptic, Clear Eyes, Luden's, DenTek, BC Powder, Goody's, Boudreaux's Butt Paste, Compound W, Nix, Monistat, Summer's Eve, TheraTears, Fleet, and Efferdent — across digestive, eye/ear/nose/throat, oral, pediatric, pain, skin, sleep, and women's health categories. Products are sold to consumers through mass retailers, pharmacies, drug chains, grocery stores, and warehouse clubs in the US, Canada, Australia, and other international markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Pro forma sales of $1.3 billion following Breathe Right acquisition
Product overview1 text field

Prestige Consumer Healthcare operates as a diversified consumer healthcare product company with an extensive portfolio of over-the-counter (OTC) healthcare brands spanning eight product categories: Digestive Care (Tagamet, Fleet, beano, Phazyme, Bacid, Kondremul, Mag-Ox 400, Uro-Mag, Dramamine), Eye/Ear/Nose/Throat (Clear Eyes, TheraTears, Chloraseptic, Luden's, Debrox, Nasalcrom, Nōstrilla, Stye), Oral Care (DenTek, Efferdent, Effergrip, Gly-Oxide, Orabrush, The Doctor's), Pediatric Care (Boudreaux's Butt Paste, Pedia-Lax, Little Remedies, Caldesene), Pain Relief (BC Powder, Goody's, Anacin, Ecotrin, Stanback, Percogesic, Zostrix), Skin Care (Compound W, Nix, Dermarest, Americaine, Boil-Ease), Women's Health (Monistat, Summer's Eve, Uristat, Vitron-C), and Sleep Aids. The company's product strategy centers on acquiring and managing established OTC brands with strong consumer loyalty and market positions, rather than developing a unified software platform. Recent acquisitions include Breathe Right nasal strips ($1.045B) and LaCorium Australian skin care ($150M), expanding into sleep/better-breathing and skin care categories respectively. The company also launched TheraTears brand extensions (Eyelid Cleansing Wipes, Dry & Tired Eye Drops) in February 2026 targeting screen-related eye fatigue.

Product and service46 records
1Dramamine
CategoryAcquired Brand — Digestive Care / Motion Sickness
Description

Motion sickness relief and prevention product (the #1 pharmacist-recommended brand) for nausea, vomiting, and dizziness associated with motion sickness, sold to general consumers through retail.

2Tagamet
CategoryAcquired Brand — Digestive Care / Heartburn
Description

Heartburn relief and prevention medication, clinically proven and trusted for more than 40 years; FDA approved as a safe alternative to Ranitidine, sold to consumers for self-treatment of heartburn.

3Chloraseptic
CategoryAcquired Brand — Eye/Ear/Nose/Throat / Sore Throat
Description

#1 sore throat relief brand offering lozenges, fast-acting sprays, and kids spray in multiple flavors for immediate sore throat pain relief, sold to consumers in retail.

4Clear Eyes
CategoryAcquired Brand — Eye/Ear/Nose/Throat / Eye Care
Description

#1 selling brand of eye drops providing up to 12 hours of soothing comfort for redness, itchiness, dryness, and irritation relief, sold to general consumers at retail.

5Luden's
CategoryAcquired Brand — Eye/Ear/Nose/Throat / Throat Care
Description

Throat drops that soothe and relieve minor, everyday throat irritation, available in many flavors, with over 130 years of heritage, sold at retail.

6DenTek
CategoryAcquired Brand — Oral Care
Description

Oral care products including floss picks, dental guards, tongue cleaners, and breath fresheners designed for daily oral care beyond brushing, sold to consumers at retail.

7BC Powder Pain Relievers
CategoryAcquired Brand — Pain Relief
Description

Fast pain relief powders for tough headaches and pain, available in original formula, arthritis strength, cherry, and sinus/cold & flu on-the-go stick packs, sold to consumers at retail.

8Goody's Powder Pain Relievers
CategoryAcquired Brand — Pain Relief
Description

Fast-acting pain relief powders with a unique dual-action formula for minor aches and pains, including headache, body pain, and PM formulations, sold to consumers at retail.

9Boudreaux's Butt Paste
CategoryAcquired Brand — Pediatric Care
Description

Pediatrician-recommended diaper rash treatment providing instant protection and fast relief, paraben/preservative/phthalate-free, sold to parents/caregivers at retail.

10Compound W
CategoryAcquired Brand — Skin Care
Description

#1 dermatologist and pharmacist recommended wart removal products, including gels, liquids, freezing methods, and Compound W NitroFreeze, sold to consumers at retail.

11Nix
CategoryAcquired Brand — Skin Care / Lice Treatment
Description

#1 pediatrician and pharmacist recommended lice removal products, killing head lice and eggs including Super Lice, with treatments, prevention sprays, and a lice tracker tool, sold to parents at retail.

12Monistat
CategoryAcquired Brand — Women's Health
Description

#1 gynecologist-recommended OTC yeast infection treatment (relieves symptoms faster than leading prescription) and the Monistat Care line for symptom relief and feminine cosmetic products, sold to women at retail.

13Summer's Eve
CategoryAcquired Brand — Women's Health
Description

Clinically and gynecologist-tested feminine hygiene products (washes, cloths, sprays, douches) for odor removal and freshness, sold to women at retail.

14TheraTears
CategoryAcquired Brand — Eye/Ear/Nose/Throat / Dry Eye
Description

Dry eye relief line created by an ophthalmologist after 18 years of research, including lubricant eye drops, eyelid cleanser, and Omega-3 supplement; the 2026 brand extensions (Eyelid Cleansing Wipes, Dry & Tired Preservative Free Lubricant Eye Drops) target screen-related eye fatigue, sold to consumers at retail.

15Fleet
CategoryAcquired Brand — Digestive Care
Description

#1 enema and suppository brand with over 140 years of experience providing gentle, effective, fast relief from occasional constipation; manufactured at the Fleet Laboratories facility in Lynchburg, VA, sold to consumers at retail.

16Nasalcrom
CategoryAcquired Brand — Eye/Ear/Nose/Throat / Allergy
Description

Nasal allergy spray that prevents nasal allergy symptoms from occurring when used as directed (unlike most allergy medications that only treat symptoms), sold to consumers at retail.

17Nōstrilla
CategoryAcquired Brand — Eye/Ear/Nose/Throat / Nasal Decongestant
Description

Nasal decongestant spray providing fast relief for stuffy noses lasting up to 12 hours via fast-acting metered pump spray, sold to consumers at retail.

18Boil-Ease
CategoryAcquired Brand — Skin Care
Description

Fast, maximum strength boil pain relief ointment, sold to consumers at retail.

19Americaine
CategoryAcquired Brand — Skin Care / Pain Relief
Description

Hospital-formula pain-relieving spray and hemorrhoidal ointment containing 20% benzocaine (the highest level available without a prescription), sold to consumers at retail.

20Debrox
CategoryAcquired Brand — Eye/Ear/Nose/Throat
Description

#1 doctor and pharmacist recommended earwax removal drops with unique microfoam cleansing action; also includes Debrox Swimmer's Ear for water-clogged ears, sold to consumers at retail.

21Stye
CategoryAcquired Brand — Eye/Ear/Nose/Throat
Description

#1 selling stye treatment offering sterile lubricant eye ointment and an eye therapy warming compress for safe, effective stye and dry eye relief, sold to consumers at retail.

22Vitron-C
CategoryAcquired Brand — Women's Health / Supplement
Description

High-potency iron dietary supplement with Vitamin C to aid iron absorption and build iron reserves, sold to consumers at retail.

23Uristat
CategoryAcquired Brand — Women's Health
Description

Urinary health product containing the #1 doctor-recommended OTC ingredient for fast, temporary relief of Urinary Tract Infection symptoms, sold to consumers at retail.

24Orabrush
CategoryAcquired Brand — Oral Care
Description

Tongue cleaner with ultra-soft, micro-pointed bristles designed to fight bad breath by reaching deep into tongue crevices, sold to consumers at retail.

25Efferdent
CategoryAcquired Brand — Oral Care
Description

Denture cleanser that cleans full plate dentures, partials, retainers, and other dental appliances using effervescence to power away tough stains and kill 99.9% of odor-causing bacteria, sold to consumers at retail.

26Effergrip
CategoryAcquired Brand — Oral Care
Description

Extra-strong, zinc-free denture adhesive providing a powerful grip for denture wearers, sold to consumers at retail.

27Gly-Oxide
CategoryAcquired Brand — Oral Care
Description

Antiseptic oral cleanser for canker sores, minor wounds, gum inflammation, and everyday oral hygiene (kills germs and reduces mouth odors), sold to consumers at retail.

28The Doctor's NightGuard
CategoryAcquired Brand — Oral Care
Description

Affordable moldable mouth guard (NightGuard dental protector) to protect teeth from nighttime teeth grinding and bruxism, sold to consumers at retail.

29Bacid
CategoryAcquired Brand — Digestive Care
Description

Probiotic containing the same live and active cultures found in yogurt to help maintain a healthy digestive system and support the body's natural defense, sold to consumers at retail.

30beano
CategoryAcquired Brand — Digestive Care
Description

Gas prevention product taken before meals to prevent gas, bloating, and discomfort before it starts, sold to consumers at retail.

31Phazyme
CategoryAcquired Brand — Digestive Care
Description

Strongest gas-fighting medicine providing fast relief from gas, bloating, and pressure in minutes, including a heartburn relief formulation, sold to consumers at retail.

32Kondremul
CategoryAcquired Brand — Digestive Care
Description

Lubricant laxative for relief of occasional constipation, providing gentle, predictable regularity without straining or dehydration, sold to consumers at retail.

33Mag-Ox 400
CategoryAcquired Brand — Digestive Care / Supplement
Description

#1 pharmacist-recommended magnesium supplement, in the most concentrated form available in pharmaceutical-grade quality, sugar and gluten free, sold to consumers at retail.

34Uro-Mag
CategoryAcquired Brand — Digestive Care / Supplement
Description

Pharmaceutical-grade low-dose magnesium supplement, sugar and gluten free, sold to consumers at retail.

35Pedia-Lax
CategoryAcquired Brand — Pediatric Care
Description

#1 pediatric laxative brand, the only laxative designed specifically for kids, providing safe, gentle, and effective constipation relief within minutes to hours, sold to parents at retail.

36Little Remedies
CategoryAcquired Brand — Pediatric Care
Description

Safe, reliable pediatric products for children and infants to relieve common symptoms such as dry noses, tummy discomfort, and fevers without unnecessary ingredients, sold to parents at retail.

37Caldesene
CategoryAcquired Brand — Pediatric Care
Description

Skin-soothing powder for wetness protection for the whole family, trusted for treating diaper rash, prickly heat, and chafing, sold to consumers at retail.

38Zostrix
CategoryAcquired Brand — Pain Relief
Description

Maximum-strength pain relief using the natural power of chili peppers (capsaicin) to block the body's pain messenger, sold to consumers at retail.

39Ecotrin
CategoryAcquired Brand — Pain Relief
Description

Safety-coated aspirin, a cardiologist-recommended brand for heart health and stomach safety in an aspirin regimen, sold to consumers at retail.

40Anacin
CategoryAcquired Brand — Pain Relief
Description

Fast headache and pain relief using an aspirin and caffeine combination, where caffeine enhances aspirin's pain-relieving power, sold to consumers at retail.

41Stanback
CategoryAcquired Brand — Pain Relief
Description

Headache powder used to relieve mild to moderate pain from muscle aches, toothaches, common colds, headaches, and arthritis pain, sold to consumers at retail.

42Dermarest
CategoryAcquired Brand — Skin Care
Description

Psoriasis treatment with salicylic acid and a unique zinc complex formulated to treat psoriasis, remove and control scaling, soothe irritation, relieve itching, and restore moisture, sold to consumers at retail.

43Percogesic
CategoryAcquired Brand — Pain Relief
Description

Fast pain relief products for temporary relief of common aches and pains in Original and Extra Strength formulations, sold to consumers at retail.

44Breathe Right
CategoryAcquired Brand — Sleep Aids / Nasal Care
Description

Nasal strip brand for better breathing and sleep, sold to consumers at retail; added to the Prestige portfolio via $1.045B acquisition announced March 2026.

45LaCorium
CategoryAcquired Brand — Skin Care (Australia)
Description

Australian skin-care brand added to the Prestige portfolio via a $150 million acquisition in May 2026, expanding the company's international skin-care presence.

46Dimetapp
CategoryAcquired Brand — Pediatric Care / Cold & Cough
Description

Children's cough and cold treatment brand, sold to parents at retail.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeOthersAnnounced on2026-03-20
Description

Prestige Consumer Healthcare acquired the Breathe Right brand for $1.045 billion in March 2026. This acquisition expands the company's portfolio into sleep and better-breathing categories through nasal strip products. The deal was expected to close in the first half of fiscal 2027 pending regulatory approvals.

Strategic tierCoreTypeOthersAnnounced on2026-01-01
Description

Prestige Consumer Healthcare completed a $150 million acquisition of Australian skin-care firm LaCorium during fiscal 2026. This acquisition was not disclosed to investors on the Q3 earnings call or included in forward guidance, which became subject of securities fraud investigation.

Strategic tierMinorTypeOthers
Description

Australian subsidiary operations for Prestige Consumer Healthcare, maintaining presence in the Australian OTC healthcare market.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Subsidiary company operating in Australian market, distributing Prestige Consumer Healthcare products.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global CPG owner of Mucinex, Delsym, Gaviscon, and Clearasil in OTC/health; competes head-to-head in cough/cold and digestive categories with Prestige's Chloraseptic, Luden's, Tagamet, and Gaviscon-style adjacencies.

TypeBroad incumbent
Description

Owns Vicks, Pepto-Bismol, Metamucil, and Align — directly competing brands in cough/cold and digestive OTC categories that sit on the same retailer shelves as Prestige products.

TypeDirect peer
Description

Spun out from Johnson & Johnson in 2023, Kenvue is the largest pure-play consumer health company with Tylenol, Motrin, Zyrtec, Band-Aid, and Neutrogena — directly competitive in OTC pain, allergy, and women's health categories and overlapping retail buyers.

TypeOthers
Description

Pharmaceutical wholesaler and consumer health distributor that supplies many of the same retailers Prestige sells into, providing indirect comparability on US OTC distribution scale and customer relationships.

TypeOthers
Description

Largest US pharmaceutical distributor with a sizable consumer health wholesale segment; key channel counterpart for Prestige and benchmark for distribution economics across drugstores, mass, and grocery.

TypeDirect peer
Description

US-headquartered OTC and self-care leader competing in store-brand and value OTC; operates a similar portfolio of consumer healthcare products sold through mass, grocery, and drug channels directly comparable to Prestige's footprint.

TypeDirect peer
Description

Former GSK Consumer Healthcare spinout; global OTC/consumer health leader with brands like Advil, Centrum, Sensodyne, Panadol and a comparable mass retail distribution model. Most direct competitor to Prestige's brand-buyout CPG model.

TypeBroad incumbent
Description

US-listed CPG leader (Arm & Hammer, Trojan, Batiste, Orajel) with a portfolio strategy similar to Prestige's brand acquisition approach and overlapping mass-channel customer base.

TypeBroad incumbent
Description

Diversified pharma with a large Consumer Health segment (Aspirin, Claritin, Aleve, Alka-Seltzer, MiraLAX) competing directly with several Prestige brands across pain relief, allergy, and digestive care.

TypeBroad incumbent
Description

Operates a Consumer Healthcare business including Icy Hot, Gold Bond, and (historically) Chattem brands; competes with Prestige in pain relief, skin care, and women's health via shared retail buyers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A12 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Prestige Brands Holdings

Over-the-Counter (OTC) Consumer Healthcare Productsprestigebrands.com

Prestige Consumer Healthcare (NYSE: PBH) is the largest independent North American OTC consumer healthcare company, marketing, selling, and distributing an eight-category portfolio of heritage OTC brands through retail and pharmacy channels.

What Prestige Brands Holdings does

Prestige Consumer Healthcare Inc. (NYSE: PBH), historically Prestige Brands Holdings, is a publicly traded US-based consumer healthcare company that markets, sells, manufactures, and distributes over-the-counter (OTC) healthcare products. Founded around 1920 and headquartered in Tarrytown, NY, with manufacturing in Lynchburg, VA, the company describes itself as the largest independent provider of OTC products in North America and operates across the US, Canada, and Australia via its Care Pharmaceuticals subsidiary.

The company's product portfolio spans eight OTC categories (Digestive Care, Eye/Ear/Nose/Throat, Oral Care, Pediatric Care, Pain Relief, Skin Care, Sleep Aids, and Women's Health) and includes multiple #1 category leaders such as Chloraseptic, Clear Eyes, Compound W, Monistat, Fleet, Boudreaux's Butt Paste, Nix, and TheraTears. Business model is a brand-acquisition roll-up: Prestige acquires and operates heritage OTC brands (with histories ranging from 40 to 140+ years), then distributes them through pharmacies, mass retailers, and grocery stores at unit retail pricing. Recent inorganic moves include the $1.045 billion Breathe Right acquisition (March 2026) entering the sleep and nasal-strip category, the $150 million LaCorium Australian skin-care deal (2026), and the ~$108.9 million Pillar5 Pharma deal (August 2025), which collectively push pro forma sales to $1.3 billion but push leverage above 4x EBITDA and add non-disclosure-related securities-fraud scrutiny.

Revenue is generated through traditional retail channels with no public pricing or subscription model disclosed; a secondary healthcare-professional recommendation layer and a digital marketing stack (Google Analytics, Facebook/Meta, YouTube, Ketch for privacy) support demand. The product/technology stack is non-software, with no proprietary AI/ML capability or developer-facing platform; competitive advantage rests on brand equity, retail distribution, and category leadership rather than technology differentiation.

Prestige Brands Holdings firmographics

Firmographics
Name
Prestige Brands Holdings
Legal name
Prestige Consumer Healthcare Inc.
Website
https://prestigebrands.com
Company type
Public
Founded year
1920
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Prestige Consumer Healthcare (NYSE: PBH) is the largest independent North American OTC consumer healthcare company, marketing, selling, and distributing an eight-category portfolio of heritage OTC brands through retail and pharmacy channels.
Ownership category
akta.pro rank

Prestige Brands Holdings industry classification

Industry
Product category
Over-the-Counter (OTC) Consumer Healthcare Products
NAICS
Pharmacies and Drug Retailers (456110), Other Health and Personal Care Retailers (45619)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
akta.pro secondary industries
OTC & Consumer Health Distributors (HLAIAJAC), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Nonfood Grocery & HBC Wholesale (Paper, Cleaning, Personal Care) (AFAIABAL)

Keywords

  • Consumer healthcare products
  • Over-the-counter medications
  • OTC pharmaceuticals
  • Personal care brands
  • Health and wellness products

Where Prestige Brands Holdings is headquartered

Location

Headquarters

HQ city
Lynchburg
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Prestige Brands Holdings business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure

Revenue model

  1. Consumer Healthcare Product Sales: Prestige Consumer Healthcare generates revenue through the sale of over-the-counter (OTC) healthcare products. The company manufactures and distributes a portfolio of trusted consumer healthcare brands including digestive care, eye/ear/nose/throat, oral care, pediatric care, pain relief, skin care, sleep aids, and women's health products. Revenue is generated through retail distribution channels including pharmacies, mass retailers, and grocery stores.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goConsumer OTC healthcare products

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Prestige Brands Holdings product offering

Product offering

Core offering

Prestige Consumer Healthcare (NYSE: PBH) is the largest independent provider of over-the-counter (OTC) consumer healthcare products in North America. The company markets, manufactures, and distributes a portfolio of trusted legacy brands — including Dramamine, Tagamet, Chloraseptic, Clear Eyes, Luden's, DenTek, BC Powder, Goody's, Boudreaux's Butt Paste, Compound W, Nix, Monistat, Summer's Eve, TheraTears, Fleet, and Efferdent — across digestive, eye/ear/nose/throat, oral, pediatric, pain, skin, sleep, and women's health categories. Products are sold to consumers through mass retailers, pharmacies, drug chains, grocery stores, and warehouse clubs in the US, Canada, Australia, and other international markets.

Product overview

Prestige Consumer Healthcare operates as a diversified consumer healthcare product company with an extensive portfolio of over-the-counter (OTC) healthcare brands spanning eight product categories: Digestive Care (Tagamet, Fleet, beano, Phazyme, Bacid, Kondremul, Mag-Ox 400, Uro-Mag, Dramamine), Eye/Ear/Nose/Throat (Clear Eyes, TheraTears, Chloraseptic, Luden's, Debrox, Nasalcrom, Nōstrilla, Stye), Oral Care (DenTek, Efferdent, Effergrip, Gly-Oxide, Orabrush, The Doctor's), Pediatric Care (Boudreaux's Butt Paste, Pedia-Lax, Little Remedies, Caldesene), Pain Relief (BC Powder, Goody's, Anacin, Ecotrin, Stanback, Percogesic, Zostrix), Skin Care (Compound W, Nix, Dermarest, Americaine, Boil-Ease), Women's Health (Monistat, Summer's Eve, Uristat, Vitron-C), and Sleep Aids. The company's product strategy centers on acquiring and managing established OTC brands with strong consumer loyalty and market positions, rather than developing a unified software platform. Recent acquisitions include Breathe Right nasal strips ($1.045B) and LaCorium Australian skin care ($150M), expanding into sleep/better-breathing and skin care categories respectively. The company also launched TheraTears brand extensions (Eyelid Cleansing Wipes, Dry & Tired Eye Drops) in February 2026 targeting screen-related eye fatigue.

Differentiator

Problem solved

Functional benefit

Brands

  • Dramamine: Motion sickness relief and prevention products
  • Tagamet
  • Chloraseptic
  • Clear Eyes
  • Luden's
  • DenTek
  • BC Powder
  • Goody's Powder
  • Boudreaux's Butt Paste
  • Compound W
  • Nix
  • Monistat
  • Summer's Eve
  • TheraTears
  • Fleet
  • Breathe Right
  • Dimetapp
  • LaCorium

Products and services

  • Dramamine Motion sickness relief and prevention product (the #1 pharmacist-recommended brand) for nausea, vomiting, and dizziness associated with motion sickness, sold to general consumers through retail.
  • Tagamet Heartburn relief and prevention medication, clinically proven and trusted for more than 40 years; FDA approved as a safe alternative to Ranitidine, sold to consumers for self-treatment of heartburn.
  • Chloraseptic #1 sore throat relief brand offering lozenges, fast-acting sprays, and kids spray in multiple flavors for immediate sore throat pain relief, sold to consumers in retail.
  • Clear Eyes #1 selling brand of eye drops providing up to 12 hours of soothing comfort for redness, itchiness, dryness, and irritation relief, sold to general consumers at retail.
  • Luden's Throat drops that soothe and relieve minor, everyday throat irritation, available in many flavors, with over 130 years of heritage, sold at retail.
  • DenTek Oral care products including floss picks, dental guards, tongue cleaners, and breath fresheners designed for daily oral care beyond brushing, sold to consumers at retail.
  • BC Powder Pain Relievers Fast pain relief powders for tough headaches and pain, available in original formula, arthritis strength, cherry, and sinus/cold & flu on-the-go stick packs, sold to consumers at retail.
  • Goody's Powder Pain Relievers Fast-acting pain relief powders with a unique dual-action formula for minor aches and pains, including headache, body pain, and PM formulations, sold to consumers at retail.
  • Boudreaux's Butt Paste Pediatrician-recommended diaper rash treatment providing instant protection and fast relief, paraben/preservative/phthalate-free, sold to parents/caregivers at retail.
  • Compound W #1 dermatologist and pharmacist recommended wart removal products, including gels, liquids, freezing methods, and Compound W NitroFreeze, sold to consumers at retail.
  • Nix #1 pediatrician and pharmacist recommended lice removal products, killing head lice and eggs including Super Lice, with treatments, prevention sprays, and a lice tracker tool, sold to parents at retail.
  • Monistat #1 gynecologist-recommended OTC yeast infection treatment (relieves symptoms faster than leading prescription) and the Monistat Care line for symptom relief and feminine cosmetic products, sold to women at retail.
  • Summer's Eve Clinically and gynecologist-tested feminine hygiene products (washes, cloths, sprays, douches) for odor removal and freshness, sold to women at retail.
  • TheraTears Dry eye relief line created by an ophthalmologist after 18 years of research, including lubricant eye drops, eyelid cleanser, and Omega-3 supplement; the 2026 brand extensions (Eyelid Cleansing Wipes, Dry & Tired Preservative Free Lubricant Eye Drops) target screen-related eye fatigue, sold to consumers at retail.
  • Fleet #1 enema and suppository brand with over 140 years of experience providing gentle, effective, fast relief from occasional constipation; manufactured at the Fleet Laboratories facility in Lynchburg, VA, sold to consumers at retail.
  • Nasalcrom Nasal allergy spray that prevents nasal allergy symptoms from occurring when used as directed (unlike most allergy medications that only treat symptoms), sold to consumers at retail.
  • Nōstrilla Nasal decongestant spray providing fast relief for stuffy noses lasting up to 12 hours via fast-acting metered pump spray, sold to consumers at retail.
  • Boil-Ease Fast, maximum strength boil pain relief ointment, sold to consumers at retail.
  • Americaine Hospital-formula pain-relieving spray and hemorrhoidal ointment containing 20% benzocaine (the highest level available without a prescription), sold to consumers at retail.
  • Debrox #1 doctor and pharmacist recommended earwax removal drops with unique microfoam cleansing action; also includes Debrox Swimmer's Ear for water-clogged ears, sold to consumers at retail.
  • Stye #1 selling stye treatment offering sterile lubricant eye ointment and an eye therapy warming compress for safe, effective stye and dry eye relief, sold to consumers at retail.
  • Vitron-C High-potency iron dietary supplement with Vitamin C to aid iron absorption and build iron reserves, sold to consumers at retail.
  • Uristat Urinary health product containing the #1 doctor-recommended OTC ingredient for fast, temporary relief of Urinary Tract Infection symptoms, sold to consumers at retail.
  • Orabrush Tongue cleaner with ultra-soft, micro-pointed bristles designed to fight bad breath by reaching deep into tongue crevices, sold to consumers at retail.
  • Efferdent Denture cleanser that cleans full plate dentures, partials, retainers, and other dental appliances using effervescence to power away tough stains and kill 99.9% of odor-causing bacteria, sold to consumers at retail.
  • Effergrip Extra-strong, zinc-free denture adhesive providing a powerful grip for denture wearers, sold to consumers at retail.
  • Gly-Oxide Antiseptic oral cleanser for canker sores, minor wounds, gum inflammation, and everyday oral hygiene (kills germs and reduces mouth odors), sold to consumers at retail.
  • The Doctor's NightGuard Affordable moldable mouth guard (NightGuard dental protector) to protect teeth from nighttime teeth grinding and bruxism, sold to consumers at retail.
  • Bacid Probiotic containing the same live and active cultures found in yogurt to help maintain a healthy digestive system and support the body's natural defense, sold to consumers at retail.
  • beano Gas prevention product taken before meals to prevent gas, bloating, and discomfort before it starts, sold to consumers at retail.
  • Phazyme Strongest gas-fighting medicine providing fast relief from gas, bloating, and pressure in minutes, including a heartburn relief formulation, sold to consumers at retail.
  • Kondremul Lubricant laxative for relief of occasional constipation, providing gentle, predictable regularity without straining or dehydration, sold to consumers at retail.
  • Mag-Ox 400 #1 pharmacist-recommended magnesium supplement, in the most concentrated form available in pharmaceutical-grade quality, sugar and gluten free, sold to consumers at retail.
  • Uro-Mag Pharmaceutical-grade low-dose magnesium supplement, sugar and gluten free, sold to consumers at retail.
  • Pedia-Lax #1 pediatric laxative brand, the only laxative designed specifically for kids, providing safe, gentle, and effective constipation relief within minutes to hours, sold to parents at retail.
  • Little Remedies Safe, reliable pediatric products for children and infants to relieve common symptoms such as dry noses, tummy discomfort, and fevers without unnecessary ingredients, sold to parents at retail.
  • Caldesene Skin-soothing powder for wetness protection for the whole family, trusted for treating diaper rash, prickly heat, and chafing, sold to consumers at retail.
  • Zostrix Maximum-strength pain relief using the natural power of chili peppers (capsaicin) to block the body's pain messenger, sold to consumers at retail.
  • Ecotrin Safety-coated aspirin, a cardiologist-recommended brand for heart health and stomach safety in an aspirin regimen, sold to consumers at retail.
  • Anacin Fast headache and pain relief using an aspirin and caffeine combination, where caffeine enhances aspirin's pain-relieving power, sold to consumers at retail.
  • Stanback Headache powder used to relieve mild to moderate pain from muscle aches, toothaches, common colds, headaches, and arthritis pain, sold to consumers at retail.
  • Dermarest Psoriasis treatment with salicylic acid and a unique zinc complex formulated to treat psoriasis, remove and control scaling, soothe irritation, relieve itching, and restore moisture, sold to consumers at retail.
  • Percogesic Fast pain relief products for temporary relief of common aches and pains in Original and Extra Strength formulations, sold to consumers at retail.
  • Breathe Right Nasal strip brand for better breathing and sleep, sold to consumers at retail; added to the Prestige portfolio via $1.045B acquisition announced March 2026.
  • LaCorium Australian skin-care brand added to the Prestige portfolio via a $150 million acquisition in May 2026, expanding the company's international skin-care presence.
  • Dimetapp Children's cough and cold treatment brand, sold to parents at retail.

Quantifiable outcome

  • Pro forma sales of $1.3 billion following Breathe Right acquisition

Companies that use Prestige Brands Holdings

Customer profile

Segments2 records

Ideal customer profiles2 records

Prestige Brands Holdings technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Prestige Brands Holdings partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Breathe Right (Acquisition)coreOthers · 20 March 2026Prestige Consumer Healthcare acquired the Breathe Right brand for $1.045 billion in March 2026. This acquisition expands the company's portfolio into sleep and better-breathing categories through nasal strip products. The deal was expected to close in the first half of fiscal 2027 pending regulatory approvals.
  • LaCorium (Acquisition)coreOthers · 1 January 2026Prestige Consumer Healthcare completed a $150 million acquisition of Australian skin-care firm LaCorium during fiscal 2026. This acquisition was not disclosed to investors on the Q3 earnings call or included in forward guidance, which became subject of securities fraud investigation.
  • Care PharmaceuticalsminorOthersAustralian subsidiary operations for Prestige Consumer Healthcare, maintaining presence in the Australian OTC healthcare market.
  • Care PharmaceuticalsminorChannel Partner/ Reseller/ DistributorSubsidiary company operating in Australian market, distributing Prestige Consumer Healthcare products.

Scale indicators9 records

Recent moves5 records

Expansion highlights6 records

Prestige Brands Holdings competitors and assessment

Company assessment

Direct peers

  • Reckitt Benckiser Group plc: Global CPG owner of Mucinex, Delsym, Gaviscon, and Clearasil in OTC/health; competes head-to-head in cough/cold and digestive categories with Prestige's Chloraseptic, Luden's, Tagamet, and Gaviscon-style adjacencies.
  • Kenvue Inc. Spun out from Johnson & Johnson in 2023, Kenvue is the largest pure-play consumer health company with Tylenol, Motrin, Zyrtec, Band-Aid, and Neutrogena — directly competitive in OTC pain, allergy, and women's health categories and overlapping retail buyers.
  • Perrigo Company plc: US-headquartered OTC and self-care leader competing in store-brand and value OTC; operates a similar portfolio of consumer healthcare products sold through mass, grocery, and drug channels directly comparable to Prestige's footprint.
  • Haleon plc: Former GSK Consumer Healthcare spinout; global OTC/consumer health leader with brands like Advil, Centrum, Sensodyne, Panadol and a comparable mass retail distribution model. Most direct competitor to Prestige's brand-buyout CPG model.

Broad incumbents

  • Procter & Gamble (Health Care): Owns Vicks, Pepto-Bismol, Metamucil, and Align — directly competing brands in cough/cold and digestive OTC categories that sit on the same retailer shelves as Prestige products.
  • Church & Dwight Co., Inc. US-listed CPG leader (Arm & Hammer, Trojan, Batiste, Orajel) with a portfolio strategy similar to Prestige's brand acquisition approach and overlapping mass-channel customer base.
  • Bayer AG (Consumer Health): Diversified pharma with a large Consumer Health segment (Aspirin, Claritin, Aleve, Alka-Seltzer, MiraLAX) competing directly with several Prestige brands across pain relief, allergy, and digestive care.
  • Sanofi (Consumer Healthcare): Operates a Consumer Healthcare business including Icy Hot, Gold Bond, and (historically) Chattem brands; competes with Prestige in pain relief, skin care, and women's health via shared retail buyers.

Others

  • Cardinal Health, Inc. Pharmaceutical wholesaler and consumer health distributor that supplies many of the same retailers Prestige sells into, providing indirect comparability on US OTC distribution scale and customer relationships.
  • McKesson Corporation: Largest US pharmaceutical distributor with a sizable consumer health wholesale segment; key channel counterpart for Prestige and benchmark for distribution economics across drugstores, mass, and grocery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Prestige Brands Holdings social profiles

Digital presence

Prestige Brands Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Prestige Brands Holdings leadership team

Management profile

Number of profiles

Profiles5 records

Prestige Brands Holdings subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Prestige Brands Holdings funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Prestige Brands Holdings M&A and investment

M&A and investment

M&A12 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prestige Brands Holdings

What does Prestige Brands Holdings do?

Prestige Consumer Healthcare (NYSE: PBH) is the largest independent provider of over-the-counter (OTC) consumer healthcare products in North America. The company markets, manufactures, and distributes a portfolio of trusted legacy brands — including Dramamine, Tagamet, Chloraseptic, Clear Eyes, Luden's, DenTek, BC Powder, Goody's, Boudreaux's Butt Paste, Compound W, Nix, Monistat, Summer's Eve, TheraTears, Fleet, and Efferdent — across digestive, eye/ear/nose/throat, oral, pediatric, pain, skin, sleep, and women's health categories. Products are sold to consumers through mass retailers, pharmacies, drug chains, grocery stores, and warehouse clubs in the US, Canada, Australia, and other international markets.

Is Prestige Brands Holdings a public or private company?

Prestige Brands Holdings is a public company. It is classified as public and is currently operating.

When was Prestige Brands Holdings founded?

Prestige Brands Holdings was founded in 1920. It employs 501 to 1,000 people.

Where is Prestige Brands Holdings based?

Prestige Brands Holdings is headquartered in Lynchburg, United States, in the North America region.

How does Prestige Brands Holdings make money?

One revenue line is on record: consumer Healthcare Product Sales.

Who are Prestige Brands Holdings's main competitors?

Direct peers on record are Reckitt Benckiser Group plc, Kenvue Inc., Perrigo Company plc and Haleon plc. Broad incumbents are Procter & Gamble (Health Care), Church & Dwight Co., Inc., Bayer AG (Consumer Health) and Sanofi (Consumer Healthcare). Others are Cardinal Health, Inc. and McKesson Corporation.

Does Prestige Brands Holdings have an API?

No public API is recorded for Prestige Brands Holdings.

What industry is Prestige Brands Holdings in?

Prestige Brands Holdings's product category is Over-the-Counter (OTC) Consumer Healthcare Products. Its primary akta.pro industry code is CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges), with a secondary code of HLAIAJAC, OTC & Consumer Health Distributors. Its NAICS code is 456110 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketBeat163,834 Shares in Prestige Consumer Healthcare Inc. $PBH Bought by Congress Asset Management Co.Congress Asset Management Co. bought 163,834 shares of Prestige Consumer Healthcare in Q3, valued at about $7.5 million. The company reported Q2 EPS of $0.98, beating estimates, with revenue up 6.5% year-over-year. Analysts have an average price target of $67.67.Markets DailyPrestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by Zacks ResearchZacks Research upgraded Prestige Consumer Healthcare from hold to strong-buy, while Weiss Ratings restated a sell rating. The company reported Q2 EPS of $0.98, beating estimates, with revenue up 6.5% year-over-year. Analysts set a consensus target price of $67.67.Ticker ReportPrestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash FlowPrestige Consumer Healthcare guided to $270 million or more in free cash flow for the year, citing Clear Eyes supply constraints as its largest near-term challenge. Fiscal 2026 revenue fell about 4.3%, with management expecting 1-3% organic growth in fiscal 2027. The company also reiterated a three-year outlook of roughly 10% total revenue growth.Markets DailyShineco (NASDAQ:SISI) vs. Prestige Consumer Healthcare (NYSE:PBH) Financial ReviewPrestige Consumer Healthcare and Shineco are compared on profitability, dividends, institutional ownership, risk, valuation, earnings, and analyst recommendations. Prestige Consumer Healthcare beats Shineco on all 14 factors, with higher revenue, net margins, and a consensus target price of $70.75 implying 57.51% upside.GurufocusPrestige Consumer Healthcare Inc (PBH) Shares Fall 3.2% -- WhatPrestige Consumer Healthcare Inc shares fell 3.2% to $44.97 on September 18, 2026. The stock trades 37.5% below its GF Value estimate of $71.99, with a GF Score of 65/100. Insiders sold $0.4 million in shares over the past year, while gurus hold mixed positions.Investing.comHow InvestingPro Fair Value spotted Prestige Healthcare’s 43% drop By Investing.comInvestingPro's Fair Value analysis flagged Prestige Consumer Healthcare as overvalued in February 2025, and shares fell 43% to $48.70. The stock's fair value was $50.69, 41% below the trading price, and revenue and earnings declined. The case illustrates how valuation models can avoid significant losses.FinancialContent Business PagePrestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer ConferencePrestige Consumer Healthcare Inc. announced that CEO Ron Lombardi and CFO Christine Sacco will participate in a fireside chat at the Barclays Global Consumer Conference on September 10, 2026. The live webcast will be available on the company's website, with a replay option afterward.Stock TitanPrestige Consumer Healthcare Joins Barclays Sept. 10Prestige Consumer Healthcare announced that CEO Ron Lombardi and CFO Christine Sacco will participate in a fireside chat at the Barclays Global Consumer Conference on September 10, 2026. The live webcast will be available on the company's website, with a replay option afterward.AInvestThe Football Stress Test That Reveals Prestige's Debt TrapPrestige Consumer Healthcare raised full-year revenue guidance to $1.315 billion, driven by $190 million in acquisitions, while net debt rose to about $2 billion. Organic revenue fell 6.6% in fiscal 2026 Q1, and the stock dropped 22% over the past year. The company now targets a year-end leverage ratio just below 4x.Beckershospitalreview39K+ bottles of eye drops recalled over sterility concerns - Becker's Hospital Review | Healthcare News & AnalysisPrestige Brands Holdings voluntarily recalled 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief on July 29 over a lack of assurance of sterility, with the FDA classifying it as Class II on Aug. 14. The recall covers 15-milliliter dropper bottles with lot number 2552A and an expiration date of Sept. 30, 2027. It follows similar ophthalmic sterility recalls by K.C. Pharmaceuticals and Lupin Pharmaceuticals this year.